Acute Repetitive Seizures Market (By Product: USL-261, NRL-1, AZ-002, Diastat Rectal Gel, Others ) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

Acute repetitive seizures (ARS) is known as recurrent, serial, or cluster seizures. It is a phenomenon in treatment-refractory epilepsy that is distinguished by a close chronological connection of seizures that surpass a patient’s typical baseline seizure occurrence. ARS poses a risk of hospitalization and/or evolution into status epilepticus, a life-threatening seizure emergency, which underscores the need for early, effective management. Benzodiazepines are usually used as needed for rescue treatment in this orphan indication, being prescribed adjunctively to patients’ chronic antiepileptic drug (AED) regimen and administered on an as-needed basis.

Market Dynamics

Growth of this market is highly attracted to including growing prevalence of neurological diseases and strong pipeline products and increasing number of regulatory approval. Moreover, growing investment on research and development is expected to offer dynamic growth opportunities as major branded drugs are in pipeline phase and are likely to be introduced in the market very soon with help of robust research and development projects. Shifting consumer base from rectal to nasal route of administration is anticipated to offer growth opportunities. However, lack of awareness towards seizures is one of the major treatment challenges in some of the countries of Asia-Pacific including India. This problem is further exaggerated due to poor accessibility of adequate health care provision, lack of affordable treatment, availability of specialist care, distance to health care facilities, and obtainability of pharmacological treatment. Moreover, the population in such countries is unaware about new treatments in neurological disorders. On the other hand, with an increase in the demand for safe alternative and cost-effective alternatives have led to the emergence of clinical studies for evaluating the safety and effectiveness of nasal route of administration in the form of nasal sprays

The market research study on “Acute Repetitive Seizures Market (By Product: USL-261, NRL-1, AZ-002, Diastat Rectal Gel, Others ) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026” offers a detailed insights on the global acute repetitive seizures market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global acute repetitive seizures market, its type, application, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global acute repetitive seizures market size and volume, and segment markets by type, application, and geography along with the information on companies operating in the market. The acute repetitive seizures market analysis is provided for major regional markets including North America, Europe, Asia-Pacific, Middle East, Latin America, Africa. For each region, the market size and volume for different segments has been covered under the scope of report. The players profiled in the report include Grupo Ferrer Internacional S.A. (ALEXZA), Neurelis, Inc., UCB S.A., and more.

Key players investigating the use of nasal sprays are anticipated to lead to successful outcomes which further created opportunities for the use of oral to rectal route of administration. Some of investigational products are anticipated to be launched in near future accelerated by increase in the number of FDA approvals and geographical expansion by market players.
The global Acute Repetitive Seizures market is segmented as below:

Market Segmentation

Market By Product

  • USL-261
  • NRL-1
  • AZ-002
  • Diastat Rectal Gel
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East
    • Saudi Arabia
    • UAE
    • Rest of Middle East
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Africa
    • South Africa
    • Egypt
    • Rest of Africa


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary